Sotabase

Career

· PhD Student (2022—), UCL DARK Lab2022–

Publications (25)

Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma.
Artificial Organs · 2009
73
cited
Proliferation rates of HepG2 cells encapsulated in alginate are increased in a microgravity environment compared with static cultures.
Artificial Organs · 2005
45
cited
Fat‐loaded HepG2 spheroids exhibit enhanced protection from Pro‐oxidant and cytokine induced damage
Journal of Cellular Biochemistry · 2007
21
cited
Putative Human Liver Progenitor Cells in Explanted Liver
Cells Tissues Organs · 2007
18
cited
Altered mitochondrial function and cholesterol synthesis influences protein synthesis in extended HepG2 spheroid cultures.
Archives of Biochemistry and Biophysics · 2004
16
cited
Developing an injectable co-formulation of two antidiabetic drugs: excipient impact on peptide aggregation and pharmacokinetic properties.
International journal of pharmaceutics · 2020
7
cited
Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations
Toxins · 2023
7
cited
118 Alginate-encapsulated HEPG2 cells in a pilot-scale fluidised bed bioreactor maintain performance in human liver failure plasma making them suitable for use in a bioartificial liver
2006
3
cited
Sulfasalazine interference with HPLC assay of 5-hydroxyindole-3-acetic acid.
Clinical Chemistry · 1995
3
cited
Restoring urea cycle function in HepG2 cells by multiple gene transfer; A cell source for a bio-artificial liver device
2006
2
cited
1086 HEPG2 cells in 3-dimensional culture exhibit elevated expression of genes associated with lipid metabolism — further evidence that cells cultured in alginate can provide the cellular component of a bioartificial liver
2003
1
cited
Novel psychoactives in New Zealand
2016
1
cited
1082 Designer cells for a bioartificial liver-restoring ornithine carbamyl transferase (OTC) activity to HEP G2 cells by transfection and 3-dimensional culture restores urea synthesis to levels
2003
Alginate biocompatibility for use in tissue engineering and cell therapy applications: biological responses to hydrogel-encapsulated HepG2 cells in vitro - leukocyte cytokine release and peripheral blood mononuclear cell proliferation
2014
A method of proliferating human hepatocyte cells
2007
A process for the propagation of human cells hepatocytafledte
2008
A rotary microgravity culture strategy promotes alginate encapsulated HepG2 cells as the biological component of a bioartificial liver.
2004
Chamber for bio-artificial liver
2007
Development of a cell-based assay to replace LD50 for botulinum toxin A1
Toxicon · 2018
Fat-loaded insulin-resistant HepG2 cells are resistant to cytokine and pro-oxidant induced damage, but become damage-susceptible after down-regulation of AMP-activated kinase
2005
Sotabase
Sam Coward | Researcher Profile | Sotabase | Sotabase